ALISON COLEMAN: Open Payments
NPI 1427500115 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,098 in 93 payments from 20 companies in 2025. Trend: 2023 $1,657 · 2024 $1,655 · 2025 $2,098
Food & beverage: $1,964Education: $133
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $631 |
| Regeneron Healthcare Solutions, Inc. | 8 | $241 |
| Amgen Inc. | 6 | $133 |
| Pharming Healthcare, Inc. | 6 | $130 |
| Novartis Pharmaceuticals Corporation | 7 | $130 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $104 |
| GENZYME CORPORATION | 4 | $96 |
| CSL Behring | 4 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $91 |
| Genentech USA, Inc. | 3 | $81 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, RUCONEST, NEFFY, AIRSUPRA, Xolair, Rhapsido.
Industry payments across TX — which companies pay providers there.
